StockData
Champions Oncology, Inc. logo

Champions Oncology, Inc. (CSBR) stock

CSBRNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends April 30
Financials through Q1 FY2027, quarter ended Jul 31, 2026Last filing: 10-Q on Sep 11, 2026Score 10/30238% above fair value
$4.59−0.09 (-1.89%)

Close on Nov 17, 2026Market cap $63.91MP/E –Yield –

Champions Oncology market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

Champions Oncology's market cap was $66.53M on Nov 11, 2026, against $90.18M a year earlier. Over the last 5 years it ranged from $53.15M to $150.55M, with a median of $83.74M.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$66.53M-30.7%
2025Dec 31, 2025$95.95M-18.3%
2024Dec 31, 2024$117.40M+53.7%
2023Dec 29, 2023$76.40M+24.9%
2022Dec 30, 2022$61.15M-45.8%
2021Dec 31, 2021$112.83M-21.8%
2020Dec 31, 2020$144.25M+49.0%
2019Dec 31, 2019$96.80M+8.0%
2018Dec 31, 2018$89.62M+110.2%
2017Dec 29, 2017$42.63M+53.7%
2016Dec 30, 2016$27.75M-10.7%
2015Dec 31, 2015$31.07M-7.1%
2014Dec 31, 2014$33.44M-22.0%
2013Dec 31, 2013$42.88M+314.3%
2012Dec 31, 2012$10.35M-60.0%
2011Dec 30, 2011$25.85M–

More Champions Oncology figures

See a number that looks wrong?